首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Ethical and Policy Considerations for Genomic Testing in Peaiatric Research: The Path Toward Disclosing Individual Research Results
【24h】

Ethical and Policy Considerations for Genomic Testing in Peaiatric Research: The Path Toward Disclosing Individual Research Results

机译:国家数据研究基因组检测的道德和政策考虑因素:揭示个人研究成果的路径

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

DNA is now commonly collected in clinical research either for immediate genomic analyses or stored for future studies. Many genomic studies were previously designed without awareness of the ethical issues that might arise regarding the disclosure of genomic test results. At the start of the Chronic Kidney Disease in Children (CKiD) Cohort Study in 2004, we did not foresee the advent of genomic technology or the associated ethical issues pertaining to genetic research in children. Recent genomic studies and ancillary proposals using genomic technology stimulated the CKiD investigators to reassess the current ethical and policy environment pertaining to genomic testing and results disclosure. We consider the issues pertaining to next generation sequencing and individual results disclosure that may guide current and future research practices.
机译:DNA现在通常在临床研究中收集,用于立即基因组分析或储存以供将来的研究。 先前,许多基因组研究在没有意识到可能出现关于披露基因组测试结果的伦理问题的情况下。 在2004年儿童慢性肾病的开始时(CKID)队列研究,我们没有预见到基因组技术的出现或与儿童遗传研究有关的相关道德问题。 最近的基因组研究和使用基因组技术的辅助提案刺激了CKID调查人员,重新评估了与基因组检测和结果披露的当前道德和政策环境。 我们考虑与下一代测序和个人成果披露有关的问题,可以指导当前和未来的研究实践。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号